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Filamentation induced by cyclic AMP (FIC)-domain enzymes cata-
lyze adenylylation or other posttranslational modifications of
target proteins to control their function. Recently, we have shown
that Fic enzymes are autoinhibited by an α-helix (αinh) that partly
obstructs the active site. For the single-domain class III Fic proteins,
the αinh is located at the C terminus and its deletion relieves auto-
inhibition. However, it has remained unclear how activation occurs
naturally. Here, we show by structural, biophysical, and enzymatic
analyses combined with in vivo data that the class III Fic protein
NmFic from Neisseria meningitidis gets autoadenylylated in cis,
thereby autonomously relieving autoinhibition and thus allowing
subsequent adenylylation of its target, the DNA gyrase subunit
GyrB. Furthermore, we show that NmFic activation is antagonized
by tetramerization. The combination of autoadenylylation and tet-
ramerization results in nonmonotonic concentration dependence of
NmFic activity and a pronounced lag phase in the progress of target
adenylylation. Bioinformatic analyses indicate that this elaborate
dual-control mechanism is conserved throughout class III Fic proteins.
adenylylation | AMPylation | posttranslational modification | enzyme
regulation | molecular timer
Fic (filamentation induced by cyclic AMP) proteins containingthe FIC domain (pfam 02661) are found in all kingdoms of life.
FIC domains encode enzymatic activities that modulate target pro-
tein function by diverse posttranslational modifications (1, 2). The
vast majority of known Fic proteins are AMP-transferases that use
ATP to catalyze the transfer of an AMP moiety onto a target hy-
droxyl side chain (3, 4). This reaction is akin to the situation in protein
kinases, which catalyze γ-phosphate transfer onto target side chains.
Only a few Fic targets have been identified to date (2). IbpA
(4) and VopS (3), two bacterial FIC-domain effectors that get
translocated into host cells, catalyze the adenylylation of Rho
GTPases, resulting in cytoskeleton collapse. Most recently, we
have found that a subset of bacterial Fic proteins adenylylates
DNA gyrase and topoisomerase IV, which leads to their inacti-
vation and cellular growth arrest (5). The structure of a FIC-
domain/target complex (6) and the catalytic mechanism have
been determined (6, 7). However, the biological functions, as
well as the molecular mechanism, of the vast majority of Fic
proteins have remained elusive. Intriguingly, in vitro automodi-
fication has been demonstrated for most Fic proteins that have
been described so far (6, 8–15), but its physiological relevance
has remained unclear.
Recently, we have shown that Fic-mediated adenylylation is
tightly regulated (8). In the native state, a helix partly obstructs
the ATP binding site with a strictly conserved Glu blocking ATP
γ-phosphate binding, thereby preventing productive/competent
substrate binding. The inhibitory α-helix (αinh) is either located
on a separate protein that forms a tight toxin/antitoxin complex
with the Fic enzyme (16) or at the N- or C-terminal position
within the same polypeptide chain. These three possibilities lead
to a classification of Fic proteins into classes I, II, and III, re-
spectively (8). Mutation of the inhibitory Glu to Gly relieves
autoinhibition, thus boosting both target and autoadenylylation
(8, 9). However, the identity of the intrinsic or extrinsic factors
that in vivo expulse the inhibitory Glu of αinh, and thereby relieve
autoinhibition, has not been investigated.
Fic proteins have evolved in bacteria and have spread by
horizontal gene transfer into all domains of life (17). Despite
structural conservation of the basic FIC-domain fold, there is
significant sequence diversity among class I and II Fic proteins.
Additionally, these two classes are frequently combined with
other protein domains toward multidomain arrangements,
demonstrating a high functional plasticity and adaptability (2).
In contrast, class III Fic proteins are highly conserved single-
domain proteins even though they are found scattered across all
classes of Proteobacteria (8). This conservation suggests that
class III Fic proteins are stand-alone autoregulated functional
entities that act in a plug-and-play manner upon acquisition by
horizontal gene transfer.
Here, we dissect the regulatory mechanism of NmFic from
Neisseria meningitidis as representative for the class III Fic pro-
teins. First, we identify the B-subunit of DNA gyrase as the main
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bacterial target of NmFic, as for class I Fic proteins (5). We then
reveal the crucial role of autoadenylylation in the activation of
class III Fic proteins and the opposing role of oligomerization,
resulting in a peculiar and intriguing NmFic concentration de-
pendence of target adenylylation. Ultimately, because the olig-
omerization interfaces are either highly conserved or covaried,
and because the modifiable residue Y183 is strictly conserved in
class III Fic proteins, we anticipate that the combination of
oligomer dissociation and subsequent cis-autoadenylylation is
the major regulatory mechanism of class III Fic proteins.
Results
NmFic Adenylylates DNA Gyrase. We have previously shown that
expression of inhibition-relieved mutants of various bacterial Fic
proteins slowed down the growth of ectopically expressing
Escherichia coli (8). This growth reduction correlated with in
vitro adenylylation of an endogenous protein with a mass of
about 90 kDa. Subsequently, it was shown that the class I Fic
protein VbhT adenylylates the B-subunit of the bacterial topo-
isomerases DNA gyrase (GyrB) and topoisomerase IV (ParE)
(5). The modification affects a conserved Tyr of the ATP binding-
site lid, thus interfering with ATPase and topoisomerase activity.
Because expression of (class III) NmFic in its inhibition-relieved
form (NmFicE186G) also slows down E. coli growth (8), we tested
whether NmFic modifies the same targets (Fig. 1). Corroborat-
ing our previous findings (8), NmFicwt does not adenylylate
any of the target proteins. In contrast, NmFicE186G efficiently
adenylylates N. meningitidis GyrB and the orthologous E. coli
and Mycobacterium tuberculosis proteins, but not ParE of
N. meningitidis or E. coli. Mutation of the E. coli GyrB acceptor
site (Y109F or Y109A variant) completely abrogates the effect
(Fig. 1), confirming the predicted modification. In addition, in-
dependent of the presence of the target, strong autoadenylyla-
tion of NmFicwt and NmFicE186G is observed (Fig. 1), which is
investigated further below.
Conserved Tetrameric Organization of Class III Fic Proteins. NmFic
invariably shows a tetrameric arrangement (Fig. 2 and Fig. S1) in
different crystal forms and ligation states, even when the C-ter-
minal helix is absent or disordered (Fig. S1 A–C). The tetramer is
of 222 symmetry (dimer of dimers), and its formation involves
two independent interfaces (Fig. 2 A–C and Movie S1). Interface
1 is mainly mediated by the apolar interactions of F70 and Y77,
with their respective symmetry mates, and by R71 and E102,
which form two isologous salt bridges (Fig. 2B). The interface 1
residues are strongly conserved among the 197 analyzed se-
quences of class III Fic proteins. Similarly, interface 2 is formed
by apolar residues L155 and F159, as well as the two isologous
salt bridges of R149 and E156 (Fig. 2C). These residues are not
strongly conserved, but the interacting residues show strong co-
variation with the striking charge reversal of the E-R to K-E salt
bridges in a subset of the class III proteins. Taken together,
conservation and covariance of the surface residues of NmFic
suggest that tetramer formation is of functional importance for
class III Fic proteins.
To describe the stability of the tetramer in solution, we de-
termined the dissociation constants by performing size exclusion
chromatography coupled to multiangle laser light scattering (SEC-
MALLS; Fig. 2D, Top) and analytical ultracentrifugation sedi-
mentation velocity (AUC-SV), using partially fluorescein-labeled
protein (Fig. 2D, Bottom) measurements at varying protein con-
centrations. The observed shift of apparent molecular mass and
elution volume with protein concentration in SEC-MALLS (Fig.
S2A) indicated an oligomer equilibrium with fast kinetics relative
to the duration of an SEC run. Nonlinear least squares fit of the data
with an appropriate thermodynamic model (Fig. S3A and B) yielded
the dissociation constants Kd,1 and Kd,2 for the two independent
interfaces. For NmFicwt, both values are in the low micromolar
range (Table 1). Interestingly, addition of the ATP substrate stabi-
lized the tetramer considerably (Fig. 2D, Bottom, and Table 1).
To test whether the crystallographically observed tetramer
also occurs in solution and whether it is of physiological rele-
vance, we generated NmFic variants with single point mutations
in one or both of the interfaces. Based on the crystal structure,
charge reversal mutations E102R and E156R were expected to
disrupt interfaces 1 and 2, respectively. Indeed, NmFicE102R and
NmFicE156R do not form tetramers but exhibit a concentration-
dependent monomer/dimer equilibrium (Fig. 2D). Furthermore,
the dimer dissociation constants of the two variants agree very
well with the dimer dissociation constants obtained from the fit
of the NmFicwt tetramerization data (Table 1), indicating that
the two interfaces are not allosterically coupled. In addition, the
crystal structures of NmFicE102R and NmFicE156R (Fig. S2 B–E
and Table S1) revealed virtually identical interfaces to the in-
terfaces present in the tetrameric WT protein (Fig. S2 B–E).
Finally, combination of both mutations in NmFicE102R,E156R
yielded an oligomerization-deficient monomeric mutant NmFicmono,
with a concentration-independent mass identical to the theoret-
ical mass of the monomer (Fig. 2D).
Disruption of the Tetramer Activates NmFic. To obtain insight into
the physiological role of oligomerization, the tetramerization-
deficient mutants were assayed in vivo. Taking a derivative of
E. coli K12 MG1655 (AB472) as a model organism (8), the
bacterial growth inhibition upon expression of NmFic variants
was assessed on LB-agar plates supplemented with increasing
amounts of isopropyl β-D-thiogalactopyranoside (IPTG; up to
2 mM) as a physiological readout for gyrase inactivation. Fig. 3A
shows the quantification of bacterial growth by counting colony-
forming units (CFU; also Fig. S4 A and B).
In contrast to WT NmFic, the tetramerization-deficient mu-
tants NmFicE102R, NmFicE156R, and NmFicE102R,E156R showed a
severe, IPTG-dependent, growth defect (Fig. 3A), resulting in
the loss of almost 1.5, 3.0, and 1.5 log10 CFU/mL viability, re-
spectively. In addition to the strongly reduced numbers, the
colonies exhibited a drastically smaller size (Fig. S4B). As expected,
by additional mutation of the catalytic His (H107A), the observed
growth defect was completely abolished (Fig. 3A), demonstrating
that the phenotype depends on the catalytic activity of NmFic. As
expected, the observed E. coli growth defect correlates very well
with GyrB43 adenylylation, as assayed in vitro by autoradiogra-
phy (Fig. 3B). Again, the combination of the interface mutations
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Fig. 1. NmFicE186G adenylylates GyrB. Autoradiographs obtained after in-
cubation of NmFicwt (Left) and inhibition-relieved variant NmFicE186G (9)
(Right) with 40 nM α-[32P]ATP, 15 mM MgCl2, and E. coli cell lysates over-
expressing potential targets as indicated. Incubation was for 1 h at 30 °C.
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with H107A completely suppressed both autoadenylylation and
target adenylylation.
Although all tested interface mutants are active, NmFicE102R
and NmFicE102R,E156R show lower activity than NmFicE156R. An
explanation for this reduced activity may be that the strictly con-
served acidic residue 102, which is replaced in both mutants, may
contribute to the recognition of the target protein GyrB. Note that
the autoadenylylation efficiency is very similar for all oligomeri-
zation-deficient mutants (Fig. 3 B and E), suggesting that the ac-
tive center, per se, is unperturbed. In summary, the results indicate
that NmFic tetramerization renders the enzyme incompetent for
efficient autoadenylylation and for target adenylylation.
A
B
C
D
Fig. 2. Structural and oligomeric analysis of NmFic. (A) Cartoon of the NmFic structure (PDB ID code 3S6A) with the active site motif highlighted in yellow and
the target binding site (flap) in blue. Important residues are shown in full with side-chain carbon atoms of active site residues colored in yellow, modifiable Tyr
in purple, and charged residues mediating oligomerization in magenta (interface 1) and green (interface 2). The αinh is shown in olive-green with the in-
hibitory Glu (E186) shown in full. (B) View of the crystal structure of the NmFic tetramer (222 symmetry with the twofold axes indicated) with the subunits
distinguished by color (Left) and close-up views of the dimerization interface 1, with a contact area of 835 Å2 (Right). Side-chain carbon atoms are colored
according to the conservation score [ConSurf (28)]. (C) Ninety-degree rotation of the crystal structure shown in B (Left) and close-up view of the dimerization
interface 2, with a contact area of 425 Å2 (Right). Side-chain carbon atoms are colored according to covariance probability [Gremlin (29)]. In B and C, asterisks
denote residues from the neighboring molecule. (D) Dynamic oligomerization equilibrium of NmFicwt and variants. (Top) Concentration dependence of the
apparent molecular weight as determined by SEC-MALLS for NmFicwt and oligomerization interface variants. (Bottom) Tetrameric fraction xQ of NmFicwt in
the absence and presence of 5 mM ATP and autoadenylylated NmFicwt-AMP in the presence of 5 mM ATP. The lines represent the nonlinear least squares
fitting of the monomer/oligomer equilibria according to the model shown in Fig. S3A. Resulting dissociation constants are shown in Table 1.
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NmFic Autoadenylylates a Buried Tyr in Cis. Automodification has
been observed for most Fic proteins described to date (6, 8–15).
For NmFic, the sites of autoadenylylation have been mapped to
Y183 and Y188 of the αinh by mass spectrometry (MS) (8) (Fig.
2A, purple residues). Intriguingly, and in contrast to Y188, the
strictly conserved Y183 is completely buried in the hydrophobic
core of the protein. Therefore, it can be inferred that the αinh has
to detach from the core of the protein for the Y183 adenylylation
reaction to occur. Furthermore, for steric reasons, the αinh would
no longer be able to repack after modification.
Autoadenylylation of NmFic was monitored in real-time
by circular dichroism (CD) spectroscopy. Because NmFicwt
shows little autoadenylylation (Fig. 3B), we used NmFicmono
(NmFicE102R,E156R) for this and the following analyses. Upon
addition of ATP/MgCl2, the CD spectrum of NmFicmono showed
a gradual, time-dependent decrease in amplitude of the negative
peaks at 208 and 222 nm (Fig. S5A), corresponding to a re-
duction of α-helical content. This decrease is entirely consistent
with (partial) unfolding of the αinh upon autoadenylylation.
As another readout of autoadenylylation, the thermal stability
of NmFicmono, was monitored by differential scanning fluorim-
etry (DSF; Fig. S5B). The modification resulted in significant
destabilization of the protein (decrease in melting temperature
of 8 °C), consistent with the partial loss of secondary structure
shown above and the concomitant loss of packing interactions.
Importantly, the reaction kinetics were found to be independent
of the NmFic concentration, indicating that the reaction takes
place in cis. The data obtained at various NmFicmono concentra-
tions (Fig. 4) could indeed be fitted globally with one apparent
first-order rate constant, kcat,1 (Table 2). Structural modeling
verified that upon αinh unfolding, the disordered C-terminal seg-
ment is long enough to allow Y183 to reach the target dock of the
same molecule. A model of the structural changes accompanying
NmFic autoadenylylation is shown in Movie S2.
Additionally, we tested whether the NmFicmono,H107A mutant,
which is catalytically inactive and thus incompetent for cis
modification, can be modified in trans. In mixtures of NmFicmono
and NmFicmono,H107A, the final concentration of the adenylylated
product was found to correspond closely to the final concentration
of the active NmFicmono enzyme only (Fig. S5C). This observation
corroborates the conclusion that autoadenylylation occurs in cis.
Ultimately, we subjected our samples to MS analyses (Fig. S6
A and B). Indeed, NmFicmono,H107A showed the native mass,
confirming that NmFicmono is not able to catalyze the modifi-
cation of the inactive mutant in trans. In contrast, the mass of
NmFicmono was increased by 1,316 Da, corresponding to the
mass of four AMP moieties. Thus, apart from the already
identified Tyr residues Y183 and Y188, the presence of two
more acceptor sites can be inferred. The MS analysis was also
performed on NmFicmono,Y183F (in the presence of NmFicmono)
and revealed two species corresponding to doubly and triply
modified protein. As anticipated, we did not observe modifica-
tion on four sites because the main acceptor site Y183 had been
mutated in this protein variant. Furthermore, the Y183F mutation
appears to slow down autoadenylylation (also Fig. 3G), because
the automodification reaction did not reach completion (triply
modified NmFicmono,Y183F). Reduced autoadenylylation of the
NmFicmono,Y183F mutant compared with NmFicmono was also ob-
served by autoradiography (Fig. S6 C and D). Finally, residues
Y184 and Y185 were identified as the remaining acceptor sites,
because the mutant having all four Tyr residues (Y183, Y184,
Y185, and Y188) replaced by Phe showed virtually no autoadeny-
lylation. Satisfactorily, the sequential removal of individual acceptor
sites in the combinatorial mutants resulted in a linear decrease of
the band intensity on the autoradiographs (Fig. S6 C and D).
αinh of Autoadenylylated NmFic Is Partly Unfolded. We further in-
vestigated the structural changes accompanying NmFic auto-
modification by high-resolution nuclear magnetic resonance
(NMR) spectroscopy (Fig. 5). We obtained well-dispersed
NMR spectra for an unmodified protein (catalytically inactive
NmFicmono,H107A), as well as for autoadenylylated (NmFicmono-
AMP) protein. Sequence-specific backbone resonance assign-
ments were obtained for 96% of the residues of NmFicmono,H107A
(Fig. S7A). Based on these assignments, the chemical shifts of
the autoadenylylated form could be assigned to 91% and con-
firmed by additional triple-resonance experiments. The overlay
of the 2D [15N,1H]-HSQC (heteronuclear single quantum co-
herence) spectra of the native and autoadenylylated proteins
shows large chemical shift differences for a subset of resonances
(Fig. 5A). The residue-specific analysis of chemical shift changes
upon autoadenylylation (Fig. 5 B and C) revealed that helix 8
(αinh) is the most affected region of the protein. Therein, the
covalently adenylylated residue Y183 showed the most pro-
nounced chemical shift change [Δδ(HN) = 6.7 ppm]. Further-
more, the amide chemical shifts of residues 178–191 populate
the random coil region (7.5–8.5 ppm), indicating an unfolded
conformation. In addition, the target-binding site (flap) and helix
1 (adjacent to helix 8) show significant chemical shift differences,
but to a lesser extent than the αinh, and a few residues in these
regions are broadened beyond detection (Fig. 5B). Due to the
point mutation H107A in the native form, the active site region
also shows some chemical shift differences (Fig. 5 B and C).
Despite these changes, the structural scaffold of the protein re-
mains intact upon autoadenylylation. To characterize the sec-
ondary structure elements of both NmFic forms in solution, we
used the secondary chemical shifts of the backbone 13Cα nuclei
(Fig. 5D). In aqueous solution, NmFicmono features eight α-helices,
which agree in number and positioning with the crystal structure.
The picture changes for the autoadenylylated form, in which the
first seven helices are maintained, whereas the αinh features helical
structure only in its first two helical turns, but is unfolded from the
position of residue G178 onward. These secondary structure
changes are in full agreement with the chemical shift perturbation
in 2D [15N,1H]-HSQC spectra (Fig. 5D and Movie S2). Overall,
these data confirm the hypothesis that the αinh cannot adopt its
original position and conformation upon autoadenylylation
of Y183.
NmFic Autoadenylylation Relieves Autoinhibition. We have shown
that cis-autoadenylylation of NmFic constitutes an in-built mech-
anism to covalently modify Y183, resulting in partial unfolding
of the αinh. Obviously, this modification should be of functional
relevance, considering that the αinh in its native form partially
Table 1. Biophysical characterization of NmFic oligomerization
NmFic variants
and conditions Method Kd,1, μM Kd,2, μM Kd,2′, μM
NmFicE102R MALLS 7.4 ± 1.1 — —
NmFicE156R MALLS — 60 ± 12 —
NmFicwt MALLS 7.6 ± 1.1 61 ± 9 —
NmFicwt* AUC 2.6 ± 0.1 20 —
NmFicwt (5 mM ATP)* AUC 0.71 ± 0.04 5.5 —
NmFicwt-AMP (5 mM ATP)
† AUC 0.71 — 1.1 ± 0.2
Oligomerization parameters were fitted according to the kinetic
scheme (Fig. S3A) to the data shown in Fig. 2D. Kd,1 and Kd,2 correspond
to the dissociation constants for NmFic dimerization via interfaces 1 and 2,
respectively.
*Due to the limited amount of data points, only one of the dissociation
constants (Kd,1) was fitted and the other (Kd,2) was computed, keeping
Kd,2/Kd,1 = 7.7, based on the ratio obtained for NmFicwt.
†Based on structural considerations, it can be assumed that the autoadenylylated
C-terminal segment does not affect interface 1. Therefore,Kd,1 was set to the value
obtained for the nonmodified protein, and only Kd,2′ was fitted (Fig. S3C).
E532 | www.pnas.org/cgi/doi/10.1073/pnas.1516930113 Stanger et al.
0 15 30 45 600
1
2
3
4
5
Y183F H107A 
       No preincubation              45’ preincubation 
  0  2.5   5  10  15  30  60    0  2.5  5  10  15  30  60    time (min) 
NmFic 
GyrB43 
NmFic 
GyrB43 
wt
H1
07
A
Y1
83
F
E1
02
R
E1
56
R
E1
02
R 
E1
56
R
E1
02
R
E1
56
R
E1
02
R 
E1
56
R
E1
02
R
E1
56
R
E1
02
R 
E1
56
R
A
B
C F
E156R E102R
E156R
Y183F
wt H107A E102R E156R E102R
E156R
E102R E156R E102R
E156R
E102R
105
106
107
108
109
1010
C
FU
/m
L
H107A
E156R 
NmFic 
GyrB43 
D
       No preincubation              60’ preincubation 
  0  2.5   5  10  15  30  60    0  2.5  5  10  15  30  60    time (min) 
E156R Y183F 0 15 30 45 60
0
1
2
3
4
5
Time (minutes)R
ad
io
gr
ap
h 
ba
nd
 in
te
ns
ity
 [A
U
]
NmFicE156R
NmFicE156R,Y183F
G
0
0.5
1.0
1.5
2.0
2.5
R
ad
io
gr
ap
h 
ba
nd
 in
te
ns
ity
 [A
U
]
NmFic autoadenylylation
GyrB43 adenylylation
E
Y183F H107A 
wt
H1
07
A
Y1
83
F
E1
02
R
E1
56
R
E1
02
R 
E1
56
R
E1
02
R
E1
56
R
E1
02
R 
E1
56
R
E1
02
R
E1
56
R
E1
02
R 
E1
56
R
autoadenylylation
Time (minutes)
R
ad
io
gr
ap
h 
ba
nd
 in
te
ns
ity
 [A
U
]
GyrB adenylylation
No preincubation
45’ preincubation
Fig. 3. ActivationofNmFic leads to E. coligrowthdefect and in vitro adenylylationofGyrB. (A) Quantification of E. coligrowth upon repression (1%glucose) or induction of the
expression of NmFic variants at varying inducer (IPTG) concentrations from a single-copy plasmid (left to right with a color gradient from white to black: 1% glucose, no IPTG,
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ATPase and transducer domains) at 35 °C. (B) In vitro adenylylation assaywith 1 μMpurifiedNmFic and 2.5 μMpurifiedGyrB43 using an incubation timeof 1 h. (C) Time course of
autoadenylylation and GyrB43 adenylylation by NmFicE156R with or without ATP preincubation using 1 μM NmFicE156R and 5 μM GyrB43. Note that adenylylation of GyrB43
is delayed without preincubation (i.e., activation) of the Fic enzyme. (D) Same as in C, but for NmFicE156R,Y183F. Note that this mutant is unable to adenylylate GyrB43. (E–G)
Quantification of the radiograph band intensities shown in B–D. The assumed error of 5% is depicted as error bars. (E) Bar diagram representing NmFic autoadenylylation (light
gray) and GyrB43 adenylylation (dark gray) catalyzed by the NmFic variants. (F) Time course of GyrB43 adenylylation with or without preincubation of NmFicE156R. Also
shown are the simulated curves obtained by global fitting of the kinetic model shown in Fig. 6A to the data. Resulting parameters are given in Table 2. (G) Time course of
autoadenylylation of NmFicE156R and NmFicE156R,Y183F. Fitting analogously to F yielded apparent kcat,1 values of 2.4 * 10
−3·s−1 and 4.5 * 10−4·s−1, respectively. AU, arbitrary units.
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obstructs the nucleotide binding site, and thereby autoinhibits
Fic enzymes (8). Thus, to test for any functional role of Y183, we
removed its hydroxyl group by introducing an additional Y183F
mutation into the alleles of active (i.e., oligomerization-deficient),
mutants. Strikingly, the mutation suppressed the growth defect
phenotype as efficiently as mutation of the catalytic His (H107A)
(Fig. 3A, Right), suggesting a crucial regulatory role for Y183.
The in vivo observation was faithfully mirrored in the auto-
radiograph obtained after incubation of the various purified
NmFic mutants with radioactive ATP (Fig. 3B). In vitro GyrB43
adenylylation, which is efficiently catalyzed by the three interface
mutants (Fig. 3B, lanes 4–6), is almost completely abolished in
their respective Y183F variants (Fig. 3B, lanes 10–12).
The remaining autoadenylylation of the Y183F NmFic vari-
ants (Fig. 3B, Right), which is due to the modification of Y184,
Y185, and Y188, indicates that enzyme function, per se, is not
impaired. As expected, no target adenylylation is observed. Thus,
(partial) modification of the additional Tyr residues does not
significantly relieve autoinhibition. Still, to corroborate that the
Y183F mutation had no unforeseen effect on the enzyme, we
determined the high-resolution (0.99 Å) crystal structures of
both NmFicE156R and NmFicE156R,Y183F (Fig. S4 C and D). In-
deed, the structures are virtually identical, apart from the ab-
sence of the Y183 hydroxyl group in the double mutant.
To test whether the kinetics of autoadenylylation and target
adenylylation would be of physiological relevance, we measured
time courses of product (GyrB-AMP) formation for NmFicE156R
(Fig. 3C). The apparent rate of NmFicE156R autoadenylylation
derived from Fig. 3G agrees well with the one obtained for
NmFicmono by DSF analysis (Table 2). Similarly, NmFicE156R,Y183F
shows autoadenylylation, although with a considerably slower rate
(Fig. 3 D and G). Such an effect of the Y183F mutation was also
observed for NmFicmono,Y183F by MS (Fig. S6B). As mentioned
above, the modification on residues Y184, Y185, and Y188 is
probably not of functional relevance.
Under the used conditions, NmFicE156R fully converts GyrB43 to
its adenylylated form within 1 h (Fig. 3 C and F), but with a pro-
nounced lag phase. This delay is absent in the progress curve of
preactivated Fic enzyme, which suggests again that only the ade-
nylylated form is catalytically active. This interpretation was con-
firmed quantitatively by globally fitting the respective kinetic model
(Fig. 6A, but without oligomerization) to the data (Fig. 3F). Upon
setting Km,GyrB to the experimentally determined value of 39 μM,
the fit yielded the turnover numbers of autoadenylylation (kcat,1,eff)
and target adenylylation (kcat,2) given in Table 2. Notably, kcat,1,eff
turned out to be about one order of magnitude slower that the
corresponding rate, kcat,1, as measured by DSF. Therefore, it can be
concluded that the rate-determining step of Fic activation is the
debinding of the modified segment from the active site (A0→A).
Activity Profile of NmFicwt Is a Consequence of Autoactivation
Combined with Oligomerization. We have thus shown that NmFic-
catalyzed target adenylylation is controlled by enzyme tetra-
merization as well as cis-autoadenylylation. These results were
obtained by analyses of mutants deficient in one or the other
function. What, then, would be the combined effect in the WT
enzyme? Fig. 6B shows the autoradiographs obtained after in-
cubation of NmFicwt (at varying concentrations) with GyrB43 for
various durations. At the standard enzyme concentration of 1 μM,
weak NmFicwt autoadenylylation and no significant target adenyly-
lation are observed for incubation times up to 8 h, consistent with our
earlier result (Fig. 3B, first lane). Strikingly, strong GyrB43 adenyly-
lation is observed at lower enzyme concentrations (250 nM and
lower), with an abrupt transition from 250 to 500 nM. Because this
transition occurs in a very similar range as the monomer-to-tetramer
transition (Fig. 2D, Bottom), it most probably reflects the emergence
of catalytically incompetent tetramers at higher concentrations.
Importantly, however, the catalytic incompetence of the tet-
ramer alone is not sufficient to explain the data, because not only
the tetramer/monomer ratio but also the absolute concentration
of active monomers will increase with total concentration (Fig.
S2H). To rationalize the observed effects quantitatively, we set
up a kinetic scheme including autoactivation and inactivation by
oligomerization as shown in Fig. 6A (also Fig. S3C). In this
model, autoinhibited native NmFic (N) is in equilibrium with
states N′ (αinh unfolded) and N′′ (modifiable Y183 positioned in
the active site). The latter state gets autoadenylylated at Y183 in
a first-order reaction to yield A0. Finally, unbinding of the modified
C terminus will result in a monomer state A that is predicted to be
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Fig. 4. Cis-autoadenylylation of monomeric NmFic. Progress curves of
autoadenylylation of NmFicmono acquired at the indicated protein concen-
trations using 5 mM ATP and 10 mM MgCl2. The data were fitted to a first-
order reaction model. Dotted lines are the result of individual fitting, and
plain lines are the result of global fitting of the three independent experi-
ments (apparent kcat,1 of 4.5 * 10
−3·s−1; Table 1). Note that individual and
global fitting are virtually identical.
Table 2. Enzymatic characterization of NmFic-catalyzed autoadenylylation and target
adenylylation
Reaction Parameter kcat, s
−1 Km, μM Method
Autoadenylylation
(N,N′,N′′) → (A0,A) kcat,1 (4.5 ± 0.53) 10−3 n/a DSF (Fig. 4)
(N,N′,N′′) → (A0,A) kcat,1 (2.3 ± 0.08) 10−3 n/a Adenylylation assay (Fig. 3G)
(N,N′,N′′) → A kcat,1,eff (2.1 ± 0.25) 10−4 n/a Adenylylation assay (Fig. 3F)
Target adenylylation
A + G → A + G-AMP kcat,2 0.18 ± 0.01 Adenylylation assay (Fig. 3F)
A + G → A + G-AMP Km,G 39.7 ± 3.6 Adenylylation assay (not shown)
All parameters are apparent parameters referring to an ATP concentration of 5 mM. The Kd of ATP binding to
native monomeric NmFic has been measured by NMR to 7.8 mM (Fig. S7C). The value of kcat,1 was determined by
DSF and adenylylation assay for NmFicmono and NmFicE156R, respectively. The values agree satisfactorily within a
factor of 2. n/a, not applicable.
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competent for target adenylylation. Note, that ATP binding will
shift the A0⇔A equilibrium toward the competent A state. Because
monomers are in fast oligomerization equilibrium, active A mono-
mers will repartition into the tetramer that acts as a reservoir, and will
therefore be partly sequestered to the inactive oligomeric state.
We reasoned that a contribution of the unfolded autoadenylylated
C-terminal segment to the interface might affect the oligomeri-
zation affinity. Indeed, in presence of 5 mM ATP, the dissoci-
ation constant (Kd,2′) of A was measured by AUC-SV to be
fivefold lower than the corresponding constant of N (Fig. 2D
and Table 1).
Using the experimentally determined parameters of the kinetic
model (Tables 1 and 2), we then simulated GyrB43-AMP pro-
duction as function of enzyme concentration and incubation time by
numeric integration of the respective differential equations (Fig. 6 C
and D). Indeed, as observed experimentally, target adenylylation
efficiency drops with enzyme concentration above a certain thresh-
old (Fig. 6C). Furthermore, the simulated progress curves (Fig. 6D)
reproduce the lag phase observed at a high enzyme concentration.
Taken together, the salient features of intrinsic NmFic regulation
are faithfully captured by the proposed kinetic model.
Discussion
The physiological importance of AMP-transferases with FIC fold
has escaped attention for a long time, because their activity is
kept in check by intra- or intermolecular active site obstruction
(8). In this study, we focused on class III Fic proteins that carry
the inhibitory αinh at the C terminus and are composed of a FIC
domain only. We reveal that in addition to the previously reported
autoinhibition (8), two further mechanisms inversely regulate
adenylylation activity, namely, tetramerization and cis-autoade-
nylylation. This combination results in a complex autoregulatory
mechanism.
NmFic forms a tetramer with the involved interfaces largely
conserved or coevolved among class III members, suggesting
conservation of the tetrameric arrangement in this class. Dis-
ruption of either interface was achieved by site-directed muta-
genesis, thus verifying their role both in the crystalline state and
the solubilized state. Due to the cooperative nature of tetra-
merization, a sharp monomer–tetramer transition occurs in the
presence of ATP, at the rather low NmFic concentration of
50 nM (Fig. 2D and Fig. S2G). Clearly, the tetramer state is of
physiological relevance, because expression of interface disrup-
tion mutants, but not of NmFicwt, resulted in impaired growth of
the expressing E. coli strain. Thus, it can be inferred that only
monomeric NmFic is able to exert the growth retardation effect,
which can be attributed to GyrB adenylylation (5). Most prob-
ably, the tetramer is catalytically noncompetent, because the
binding site for the segment flanking the modifiable side chain
[target dock (10)] is partially occluded. Furthermore, the strict
conservation of oligomerization interface 1 (as opposed to in-
terface 2, which shows covariation) may point to its involvement
in mediating the contact between (monomeric) NmFic and the
target. In fact, the surface-exposed area of the tetramer is highly
variable, and therefore probably not involved in target recogni-
tion (Movie S1).
Fic automodification has been reported repeatedly (6, 8–15),
but its role has remained unclear. In fact, nonspecific modifica-
tion due to the high in vitro Fic concentrations used seemed
possible. Here, we have shown that NmFic autoadenylylation
crucially controls enzyme activity by relieving the autoinhibitory
effect of the αinh, as demonstrated by the Tyr-to-Phe mutation
(Y183F) that fully suppressed the activating effect of the in-
terface disruption mutants (Fig. 3A) and rendered the enzyme
incompetent for target adenylylation (Fig. 3B). Biochemical and
structural analyses confirmed that the conservative Y183F mu-
tation does not disrupt the FIC fold (Fig. 3 and Fig. S4 C and D).
Importantly, the automodification occurs in cis with a reaction
velocity independent of the total enzyme concentration. Indeed,
structural modeling shows that upon unfolding of the αinh, the
modifiable Tyr can reach the active site of the same molecule
(Movie S2). Probably, the segment flanking the Tyr residue
would engage in β-strand interaction with the flap, resulting in
A
B
C D
Fig. 5. Structural perturbations of NmFic upon autoadenylylation. (A) Overlay
of 2D [15N,1H]-HSQC spectra of 500 μM [U-13C,15N]-labeled native inactive mo-
nomeric NmFic (NmFicmono,H107A, cyan) and of 140 μM [U-13C,15N]-labeled
autoadenylylated monomeric NmFic (NmFicmono-AMP, black). (B) Amide-group
chemical shift difference, Δδ(HN), between NmFicmono,H107A and NmFicmono-
AMP plotted as a function of NmFic residue number. Residues exhibiting sig-
nificant line broadening in the adenylylated form are indicated in gray as
negative bars. Values at positions 107 (H/A) and 183 (Y) are highlighted in blue
and purple, respectively. (C) Amide-group chemical shift differences mapped on
the structure of NmFic (PDB ID code 3S6A) using the indicated color code. The
largest chemical shift differences cluster in helices α1 and α8 (αinh) and in the
flap region. (D) Secondary 13Cα chemical shifts for residues 167–190 of native
NmFicmono,H107A (Top), autoadenylylated NmFicmono-AMP (Middle), and their
difference (Bottom) relative to the random coil values. A 1-2-1 smoothing
function was applied to the raw data. Consecutive stretches with positive
and negative values indicate α-helical and β-strand secondary structure, re-
spectively. The extent of αinh as inferred from the crystal structure of the
native NmFic is indicated on top. The full residue range is shown in Fig. S7B.
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correct registration of the modifiable tyrosyl side-chain within
the active site. This binding mode would be analogous to the one
seen in the complex structures of IbpAFic2/cdc42 (6) and of
noncognate peptide/Fic proteins (9). Because the flap is partially
buried at the center of the tetramer, the structural model also
explains why the tetramer would be incompetent for automodi-
fication. Thus, in the presence of ATP, native monomeric NmFic
gets efficiently converted to its active, covalently modified form
with a rather fast “in-built” first-order rate constant (Table 2,
equivalent to a t1/2 of about 150 s). As such, NmFic and, most
likely, Fic proteins of class III in general constitute self-con-
tained proteinaceous timers. Whether such an autoactivation
mechanism also pertains to Fic proteins of class I and II remains
to be seen, but conserved Tyr acceptor candidates can be iden-
tified in the N-terminal and central part of the fold, respectively.
Noteworthy, cis-automodification has also been described for a
few kinases as an activation mechanism (18).
The combination of the two coupled and counteracting effects,
automodification and tetramerization, results in a quite unusual
time and concentration dependence of target adenylylation, as
captured in vitro by autoradiography (Fig. 6B) and reproduced in
silico by respective simulations (Fig. 6C andD). In essence (Fig. 6A),
monomeric native Fic molecules (N) get converted with the intrinsic
first-order rate to the autoadenylylated, active form (A). However,
because Fic monomers are in fast equilibrium with the tetrameric
state, they get redistributed such that the A/N ratio will be equal or
larger in the tetrameric state. As a consequence, the increase in the
absolute number of active monomers (A) will be dampened. Obvi-
ously, this buffering effect is most pronounced at high tetramer/
monomer ratios (i.e., high enzyme concentrations) and will di-
minish when the autoadenylylation reaction reaches completion.
The comprehensive characterization of the complex auto-
regulatory mechanism of class III Fic proteins presented here
sets the stage for future investigations of its physiological con-
sequences. It has to be inferred, however, that the intrinsic reg-
ulatory mechanism may be further modulated by external factors,
such as antagonistic phosphodiesterases [e.g., the de-AMPylase
SidD of Legionella (19, 20)], specific proteases, or small ligands.
Furthermore, Fic biosynthesis and degradation, as well as dilution
effects during cell growth and division, will profoundly affect the
time profile of the Fic pool activity. Still, solely based on the in-
herent mechanism, interesting consequences can be envisaged.
The nonmonotonic dependence of AMP-transferase activity
on enzyme concentration would render the enzyme exquisitely
sensitive to variation of its concentration in the bacterial cell. A
twofold drop of NmFic concentration in the right range (e.g., due
to cellular growth and division) would drastically increase catalytic
activity, and thus GyrB inactivation. In addition, the considerable
delay in NmFic-mediated GyrB adenylylation may be important in
vivo to ensure that the growth-retarding effect of the target
modification kicks in only under certain conditions, such as star-
vation, when synthesis of fresh NmFic has come to a halt. Mo-
lecular timers have been found before, such as the master
regulator Spo0A of Bacillus that controls, upon phosphorylation,
the switch from competence to sporulation via a well-characterized
genetic circuit (21, 22) induced by prolonged times of nutriment
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Fig. 6. Concentration and time dependence of NmFicwt-catalyzed target adenylylation. (A) Simplified model of the regulatory mechanism of class III Fic
proteins. (Top Left) Native monomeric Fic protein (N) is activated by autoadenylylation to yield A. This reaction involves unfolding of the αinh (N′), binding of
the modifiable Tyr Y183 of the unfolded segment to the flap (N′′), and subsequent autoadenylylation of Y183 (A0). (Bottom) Both types of monomers (N and
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the active monomers. (Right) Only the remaining fraction of free (monomeric) A molecules is competent for target adenylylation. The complete model with
all thermodynamic and kinetic parameters is shown in Fig. S3C. (B) Autoradiographs showing NmFicwt and GyrB43 adenylylation. The same experimental
setup as in Fig. 3C was used but was carried out at various NmFicwt concentrations (1 nM to 2 μM, as indicated). Reactions were stopped after the indicated
incubation times. (C) Simulation of GyrB adenylylation as a function of total NmFicwt concentration based on the kinetic model shown in A and Fig. S3C, with pa-
rameters set to their measured values (Tables 1 and 2). (D) Replot of the data shown in C as a function of incubation time for representative NmFicwt concentrations.
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starvation. Class III Fic proteins may constitute a new family of
molecular timers that are, in contrast to the master regulator
Spo0A of Bacillus, fully autonomous and not relying on any feed-
back exerted by other components or a genetic circuit. This hy-
pothesis will have to be tested in future studies.
Materials and Methods
Detailed information on cloning, expression, purification, crystallization,
data collection, and structure determination by X-ray crystallography or
NMR is provided in SI Materials and Methods. Plasmids were constructed as
described previously (8, 23, 24) (Tables S2 and S3). Proteins were expressed
and purified as described (8, 25). Toxicity tests and adenylylation assays
were performed according to the protocols given by Harms et al. (5) and
Goepfert et al. (9).
The oligomeric state of NmFic was determined by SEC-MALLS and AUC-SV
at varying concentrations. DSF (26) was used to monitor in vitro autoade-
nylylation of NmFic. For simulations and fitting of functional data to the
kinetic model, the programs ProFit 6.2.14 (QuantumSoft) and Complex
Pathway Simulator (COPASI) 4.14 (27) were used.
Detailed information on the various experimental procedures is provided
in SI Materials and Methods.
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